Corporate Profile

Overview

Founded April 16, 1913
Incorporated April 28, 1945
Paid-In Capital ¥7.2 billion; listed on the First Section of the Tokyo Stock Exchange
Employees 1,666 (Consolidated) ※As of March 2018
Head Office 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160-8515, Japan
Tel +81-3-3358-7211
Fax +81-3-3358-7887

Members of the Board

As of October 1, 2018
President Naoyuki Mochida
Senior Executive Managing Directors Chu Sakata
Keiichi Sagisaka
Executive Managing Directors Yoichi Kono
Junichi Sakaki,Ph.D.
Kiyoshi Mizuguchi, Ph.D.
Executive Directors Hiroshi Nakamura
Ichiro Takahashi
Corporate Advisor Makoto Aoki
Outside Directors Tomoo Kugisawa
Hirokuni Sogawa

Audit & Supervisory Board Members

As of October 1, 2018
Full-time Audit & Supervisory Board Members Yoshiharu Hashimoto
Kazuhiro Miyaji
Outside Audit & Supervisory Board Members Hiroshi Watanabe
Tetsuya Kobayashi
Kyosuke Wagai

Executive Officers

As of October 1, 2018
Executive Officers Takayuki Kato
Yutaka Kawakami, Ph.D.
Kazumasa Fukuchi
Shigeharu Suzuki
Hitoshi Mizuno
Tomokazu Matsusue
Tadashi Morikawa
Masayoshi Takeda
Takeshi Mochida
Reiko Nakano

Consolidated Financial Highlights

Years ended March 31
  Millions of Yen
2019
(forecast)
2018 2017
Net sales 110,000 106,761 97,349
Operating income 7,000 11,662 11,374
Income before income taxes
and minority interests
12,116 11,583
Income taxes 3,092*1 3,057*2
Net income 6,400 9,023 8,526
Total assets 155,054 148,372
R&D expenditures 14,000 11,912 15,226
Capital expenditures 2,000 1,001 1,060
  Yen
Net income per share 322.4 454.6 429.5
Cash dividends per share 160.0 170.0 155.0
  • *1 As a result of tax effect accounting, corporate tax, resident tax and business tax (total ¥3,363 million), income taxes-deferred (-¥270 million) is included.
  • *2 As a result of tax effect accounting, corporate tax, resident tax and business tax (total ¥4,072 million), income taxes-deferred (-¥1,014 million) is included.

Sales of Main Products

Years ended March 31
  Billions of Yen
Products 2019
(forecast)
2018 2017
Tramcet® Analgesic for chronic pain and pain after tooth extraction 24.7 22.8 9.5
Epadel Drug for hyperlipidemia and arteriosclerosis obliterans 14.6 18.3 20.6
Lexapro® Antidepressant 14.8 13.7 12.1
Atelec® Calcium channel blocker with a long-acting hypotensive effect 5.5 6.7 7.8
Dinagest Therapeutic agent for endometriosis and adenomyosis 1.8 4.8 13.9
Lialda® Treatment of ulcerative colitis 3.8 2.5 0.2
Treprost® Treatment for pulmonary arterial hypertension 1.9 1.7 1.3
Heparin Sodium for Inj. MOCHIDA Anticoagulant agent 1.5 1.6 1.7
Arasena-A Antiviral drug 1.4 1.5 1.6
Miraclid Drug for treatment of shock, and acute pancreatitis 1.0 1.1 1.2
Florid® Antimycotic drug 1.0 1.0 1.0
Beselna Therapeutic agent for condyloma acuminatum and actinic keratosis 1.0 1.0 1.0
Doxil® Anticancer agent 2.7 0.6
Goofice® Treatment for chronic constipation 1.3
Generic drugs 19.2 17.8 13.2
Skin Care Products 4.9 4.7 4.4